Addus Homecare Corp

ADUS is in a Stage 2 advancing uptrend with a clear HH/HL sequence and rising EMAs under price, but recent exhaustion signals and extreme overbought conditions make timing unfavorable. Under Growth at Reasonable Price discipline, defer buying and stalk for a pullback into the rising EMA support zone.

• ↑Q1 2026 revenue $363.6M (+7.7% YoY), led by personal care
• ↑Adjusted EPS $1.62 (+14.1% YoY) signals strong earnings growth
• ↓Proposed 6.4% Medicare home health cut could slash revenue